Meridian Wealth Management LLC Invests $235,000 in Omega Healthcare Investors, Inc. (NYSE:OHI)

Meridian Wealth Management LLC acquired a new stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 5,770 shares of the real estate investment trust’s stock, valued at approximately $235,000.

A number of other hedge funds also recently bought and sold shares of the business. Citigroup Inc. grew its position in shares of Omega Healthcare Investors by 20.1% in the third quarter. Citigroup Inc. now owns 351,529 shares of the real estate investment trust’s stock valued at $14,307,000 after purchasing an additional 58,950 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Omega Healthcare Investors by 6.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 3,830,302 shares of the real estate investment trust’s stock worth $155,893,000 after buying an additional 240,006 shares during the last quarter. Smithfield Trust Co grew its holdings in Omega Healthcare Investors by 86.1% in the 3rd quarter. Smithfield Trust Co now owns 1,396 shares of the real estate investment trust’s stock valued at $58,000 after buying an additional 646 shares in the last quarter. Cypress Capital Group acquired a new stake in shares of Omega Healthcare Investors in the 3rd quarter worth $225,000. Finally, Advisors Asset Management Inc. raised its holdings in shares of Omega Healthcare Investors by 2.6% during the 3rd quarter. Advisors Asset Management Inc. now owns 118,273 shares of the real estate investment trust’s stock worth $4,814,000 after acquiring an additional 3,041 shares during the period. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Trading Down 0.0 %

NYSE OHI opened at $40.10 on Tuesday. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. The firm has a market cap of $10.82 billion, a price-to-earnings ratio of 29.48, a PEG ratio of 1.25 and a beta of 0.99. The firm has a 50 day simple moving average of $40.61 and a 200-day simple moving average of $37.12. Omega Healthcare Investors, Inc. has a one year low of $27.53 and a one year high of $44.42.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a $0.67 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 annualized dividend and a dividend yield of 6.68%. Omega Healthcare Investors’s dividend payout ratio (DPR) is 197.06%.

Insiders Place Their Bets

In other news, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The trade was a 10.96 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. This trade represents a 36.19 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Royal Bank of Canada raised their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research report on Monday, November 11th. Scotiabank raised their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a report on Monday, August 26th. Wells Fargo & Company reiterated an “overweight” rating and issued a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Truist Financial raised their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research note on Wednesday, September 4th. Finally, BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a research report on Thursday, October 31st. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $40.00.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.